EUVIMEDEUVIMED entdecken
Crossref

A multifunctional Pt/DMSN nanozyme-based colorimetric-fluorescence sensing platform for breast cancer detection

Xinrui Xue, Fang Zheng, Yujia Luo, Wenyu Chen, Yuanyuan Gao, Kun Wei

Microchimica Acta · 2025-04 · 192 (4)

DOI: 10.1007/s00604-025-07082-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microchimica Acta, online erschienen am 13.03.2025. Verfasst von Xinrui Xue und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Biology and Biological Engineering, South China University of Technology, Guangzhou, 510006, P. R. China. Hauptthemen laut MEDLINE: Breast Neoplasms, Platinum, Colorimetry, Metal Nanoparticles. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 45 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nanozyme-linked immunosorbent assay has emerged as a promising strategy for sensitive biosensing. However, the catalytic activity and stability of nanozymes affect the accuracy of immunosorbent assays. In this study, we synthesized a Pt/DMSN nanozyme with peroxidase-mimicking activity, which effectively catalyzed the oxidation of peroxidase substrate 3,3',5,5'-tetramethylbenzidin (TMB) in the presence of hydrogen peroxide. Capitalizing on its peroxidase-like activity, the Pt/DMSN nanozyme was functionalized with dual-fluorescent recognition elements (HER2-mAbs and sk6Ea aptamers) to establish a nanozyme-linked immunosorbent assay platform, which exhibited catalytic stability and substrate affinity comparable to horseradish peroxidase. The resulting Multi-Pt/DMSN platform was used to selectively distinguish HER2-positive breast cancer cells from luminal A, triple-negative breast cancer subtypes, and non-neoplastic cells, achieving a detection limit of 50 HER2-positive cells within 30 min. The combination of robust enzyme-like activity and tumor-targeting properties enables fluorescence imaging, providing dual-mode diagnostic functionality. This work presents a prospective platform for differentiating breast cancer subtypes in early diagnosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsPlatinumColorimetryMetal NanoparticlesHumansFemaleFluorescent DyesLimit of DetectionErb-b2 Receptor Tyrosine KinasesBenzidinesAptamers, NucleotideCell Line, TumorHydrogen PeroxideBiosensing TechniquesCatalysis

Stichwörter der Autor:innen

Breast cancer differentiationColorimetric assayFluorescence imagingNanozymePeroxidase mimic

Substanzen

PlatinumFluorescent DyesErb-b2 Receptor Tyrosine KinasesBenzidinesAptamers, NucleotideHydrogen Peroxide3,3',5,5'-tetramethylbenzidineERBB2 protein, human

Autor:innen und Institutionen

  • School of Biology and Biological Engineering, South China University of Technology, Guangzhou, 510006, P. R. China.
  • Sichuan Key Laboratory of Medical Imaging, North Sichuan Medical College, Nanchong, 637000, Sichuan, P. R. China. 594871494@qq.com.
  • School of Biology and Biological Engineering, South China University of Technology, Guangzhou, 510006, P. R. China. weikun@scut.edu.cn.

Zitieren

APA

Xue, X., Zheng, F., Luo, Y., Chen, W., Gao, Y., & Wei, K. (2025). A multifunctional Pt/DMSN nanozyme-based colorimetric-fluorescence sensing platform for breast cancer detection. Microchimica Acta, 192(4). https://doi.org/10.1007/s00604-025-07082-4

Vancouver

Xue X, Zheng F, Luo Y, Chen W, Gao Y, Wei K. A multifunctional Pt/DMSN nanozyme-based colorimetric-fluorescence sensing platform for breast cancer detection. Microchimica Acta. 2025;192(4). doi:10.1007/s00604-025-07082-4

BibTeX
@article{Xue2025,
  author = {Xue, Xinrui and Zheng, Fang and Luo, Yujia and Chen, Wenyu and Gao, Yuanyuan and Wei, Kun},
  title = {A multifunctional Pt/DMSN nanozyme-based colorimetric-fluorescence sensing platform for breast cancer detection},
  journal = {Microchimica Acta},
  year = {2025},
  volume = {192},
  number = {4},
  doi = {10.1007/s00604-025-07082-4}
}
Kostenlos starten →